Singapore, Singapore

David Skibinski

USPTO Granted Patents = 6 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 24(Granted Patents)


Location History:

  • Siena, IT (2013 - 2015)
  • Singapore, SG (2016 - 2020)

Company Filing History:


Years Active: 2013-2020

Loading Chart...
6 patents (USPTO):Explore Patents

Title: David Skibinski: Innovator in Vaccine Development

Introduction

David Skibinski is a prominent inventor based in Singapore, known for his significant contributions to the field of vaccine development. With a total of six patents to his name, he has made strides in creating innovative solutions that enhance immunogenicity while reducing the amount of antigens and adjuvants used in vaccines.

Latest Patents

Among his latest patents is a groundbreaking invention related to combination vaccines with lower doses of antigen and/or adjuvant. This invention focuses on combination vaccine compositions that maintain comparable immunogenicity to those with higher amounts of antigen and/or aluminium, despite having a relatively low amount of these components. Additionally, he has developed aluminium-free combination vaccine compositions that utilize an oil-in-water emulsion adjuvant. Another notable patent involves compounds and compositions as Toll-Like Receptor (TLR) activity modulators. This invention provides a novel class of compounds and immunogenic compositions that can be used to treat or prevent diseases associated with TLR 7, enhancing the effectiveness of vaccines.

Career Highlights

David has worked with notable companies in the pharmaceutical industry, including GlaxoSmithKline Biologicals and Irm LLC. His experience in these organizations has allowed him to contribute to the advancement of vaccine technology and immunology.

Collaborations

Throughout his career, David has collaborated with esteemed colleagues such as Manmohan Singh and Tom Yao Hsiang Wu. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.

Conclusion

David Skibinski's work in vaccine development exemplifies the importance of innovation in the medical field. His patents reflect a commitment to improving public health through advanced immunological solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…